Correlation Between Acrivon Therapeutics, and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Alzamend Neuro, you can compare the effects of market volatilities on Acrivon Therapeutics, and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Alzamend Neuro.
Diversification Opportunities for Acrivon Therapeutics, and Alzamend Neuro
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acrivon and Alzamend is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Alzamend Neuro
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.73 times more return on investment than Alzamend Neuro. However, Acrivon Therapeutics, is 1.73 times more volatile than Alzamend Neuro. It trades about 0.01 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.36 per unit of risk. If you would invest 547.00 in Acrivon Therapeutics, Common on December 11, 2024 and sell it today you would lose (18.00) from holding Acrivon Therapeutics, Common or give up 3.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Alzamend Neuro
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Alzamend Neuro |
Acrivon Therapeutics, and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Alzamend Neuro
The main advantage of trading using opposite Acrivon Therapeutics, and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Alzamend Neuro vs. Solid Biosciences LLC | Alzamend Neuro vs. Kezar Life Sciences | Alzamend Neuro vs. Senti Biosciences | Alzamend Neuro vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |